VERTAcef-TAZ
Description_Effects
VERTAcef-TAZ is a combination medication containing Ceftazidime and Tazobactum, used primarily in the treatment of serious bacterial infections. This combination is particularly effective against infections caused by resistant bacteria, especially in the lungs, urinary tract, abdomen, skin, and blood. Ceftazidime is a third-generation cephalosporin antibiotic that works by interfering with the synthesis of the bacterial cell wall, ultimately leading to the destruction of the bacteria. However, some bacteria produce enzymes called beta-lactamases that can break down this antibiotic and make it ineffective. Tazobactum is a beta-lactamase inhibitor that helps prevent this resistance. It protects Ceftazidime from being degraded, allowing it to retain its antibacterial activity. Together, Ceftazidime and Tazobactum provide a broader spectrum of antibacterial coverage, making VERTAcef-TAZ highly effective in treating moderate to severe infections, including those acquired in hospital settings (nosocomial infections). This combination is usually administered by injection under the supervision of a healthcare provider in a hospital or clinical setting. To ensure the best results, it is important to complete the full course of treatment even if you begin to feel better. Stopping the medication too early can lead to the recurrence of infection and contribute to antibiotic resistance. Always use this medicine under the guidance of a qualified medical professional.
